13,thirty Moreover, CCL2 has become described to boost osteoclastogenesis by inducing the expression of receptor activator of NF-κB (RANK) by osteoclast progenitors.31 RANK ligand (RANKL) further encourages the differentiation of osteoclast progenitors into practical osteoclasts, which could aggravate DP by causing alveolar bone resorption.32 These findings advise that CCL2 inhibition https://douglasv000xlw0.p2blogs.com/profile